Dose Optimization of Colistin: A Systematic Review

Autor: Amal F. Alotaibi, Manal Al-Gethamy, Asim A. Khogeer, Abdul Haseeb, Ahmad Jamal Mahrous, Zikria Saleem, Safa S. Almarzoky Abuhussain, Najla A. Obaid, Aziz Sheikh, Mahmoud E Elrggal, Abdullmoin AlQarni, Hani S. Faidah, Saleh Alghamdi
Rok vydání: 2021
Předmět:
Zdroj: Haseeb, A, Faidah, H S, Alghamdi, S, Alotaibi, A F, Elrggal, M E, Mahrous, A J, Almarzoky Abuhussain, S S, Obaid, N A, Algethamy, M, Alqarni, A, Khogeer, A A, Saleem, Z & Sheikh, A 2021, ' Dose Optimization of Colistin: A Systematic Review ', Antibiotics, vol. 10, no. 12, pp. 1454 . https://doi.org/10.3390/antibiotics10121454
Antibiotics
Antibiotics, Vol 10, Iss 1454, p 1454 (2021)
ISSN: 2079-6382
DOI: 10.3390/antibiotics10121454
Popis: Colistin is considered a last treatment option for multi-drug and extensively resistant Gram-negative infections. We aimed to assess the available data on the dosing strategy of colistin. A systematic review was performed to identify all published studies on the dose optimization of colistin. Grey literature and electronic databases were searched. Data were collected in a specified form and the quality of the included articles was then assessed using the Newcastle-Ottawa scale for cohort studies, the Cochrane bias tool for randomized clinical trials (RCT), and the Joanna Briggs Institute (JBI) critical checklist for case reports. A total of 19 studies were included, of which 16 were cohort studies, one was a RCT, and two were case reports. A total of 18 studies proposed a dosing regimen for adults, while only one study proposed a dosing schedule for pediatric populations. As per the available evidence, a loading dose of 9 million international units (MIU) of colistin followed by a maintenance dose of 4.5 MIU every 12 h was considered the most appropriate dosing strategy to optimize the safety and efficacy of treatment and improve clinical outcomes. This review supports the administration of a loading dose followed by a maintenance dose of colistin in severe and life-threatening multi-drug Gram-negative bacterial infections.
Databáze: OpenAIRE